Skip to content

Patient Site Full Prescribing Information

Oxistat LogoOxistat Logo
  • Patient Site
  • Full Prescribing Information
  • About OXISTAT Lotion
    • 3 Indications
    • Efficacy
    • Microbiology
    • Dosing and Administration
  • Patient Savings
Oxistat LogoOxistat Logo
  • Patient Site
  • Full Prescribing Information
  • About OXISTAT Lotion
    • 3 Indications
    • Efficacy
    • Microbiology
    • Dosing and Administration
  • Patient Savings
Oxistat LogoOxistat Logo
  • ABOUT OXISTAT LOTION
    • 3 Indications
    • Efficacy
    • Microbiology
    • Dosing and Administration
  • PATIENT SAVINGS
Site MapOxistat2021-07-20T10:23:46-07:00

Site Map

    • Home
    • About OXISTAT® Lotion
      • 3 Indications
      • Efficacy
      • Microbiology
      • Dosing and Administration
    • Patient Savings
    • Patient Site

Important Safety Information

For topical dermatologic use only. Not for oral, ophthalmic, or intravaginal use.

OXISTAT® (oxiconazole nitrate) Lotion is contraindicated in individuals who have shown hypersensitivity to any of its components. If a reaction suggesting sensitivity or chemical irritation should occur with the use of OXISTAT Lotion, treatment should be discontinued and appropriate therapy instituted. If signs of epidermal irritation should occur, the drug should be discontinued.

In a clinical trial with OXISTAT Lotion (N=269), the most common adverse events were burning and stinging (0.7% each) and pruritus, scaling, tingling, pain and dyshidrotic eczema (0.4% each).

The following additional adverse experiences have been reported with the topical use of oxiconazole nitrate: irritation and allergic contact dermatitis, folliculitis, erythema, papules, fissure, maceration, rash, and nodules.

You are encouraged to report negative side effects of prescription drugs to the FDA. Please visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

OXISTAT Lotion is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum.

Click here to see full Prescribing Information.

Ani Pharmaceuticals, Inc.

The information on this site is intended for U.S. residents only.
OXISTAT® is a registered trademark of Fougera Pharmaceuticals, Inc.
© 2023 ANI Pharmaceuticals, Inc. All rights reserved.

Site Map | Terms of Use | Privacy Policy | ANI Pharmaceuticals, Inc

The information on this site is intended for U.S. residents only.
10470 Rev 03/23

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

ARE YOU A HEALTHCARE PROFESSIONAL?

Yes

I am a healthcare
professional.

No

I am not a healthcare
professional.

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

Oxistat

You are now leaving OXISTAT.com

ANI Pharmaceuticals, Inc. is not responsible for the privacy policy, the content, or the accuracy of any websites accessed through a link on the OXISTAT.com site. A link to other websites does not constitute an endorsement of ANI Pharmaceuticals or the linked site, its products, or services.

The browser window or tab for OXISTAT.com will remain open. To return to OXISTAT.com at any time, close this tab or window.

Continue
STAY ON OXISTAT.COM

 

This infection can occur anywhere on the foot, but it often appears between the toes or on the bottoms or sides of the feet. Symptoms include:

  • Itching, burning, and stinging
  • Dryness and scaling on the soles and sides of the feet
  • A scaly red rash between the toes

Go to Top